Quest Diagnostics (DGX) Competitors $180.71 -2.20 (-1.20%) Closing price 03:59 PM EasternExtended Trading$180.48 -0.23 (-0.13%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DGX vs. HSIC, MEDP, AMN, LH, DVA, CHE, CRVL, AMED, MD, and CCRNShould you be buying Quest Diagnostics stock or one of its competitors? The main competitors of Quest Diagnostics include Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Labcorp (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), and Cross Country Healthcare (CCRN). Quest Diagnostics vs. Its Competitors Henry Schein Medpace AMN Healthcare Services Labcorp DaVita Chemed CorVel Amedisys Pediatrix Medical Group Cross Country Healthcare Henry Schein (NASDAQ:HSIC) and Quest Diagnostics (NYSE:DGX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Does the media favor HSIC or DGX? In the previous week, Quest Diagnostics had 7 more articles in the media than Henry Schein. MarketBeat recorded 25 mentions for Quest Diagnostics and 18 mentions for Henry Schein. Quest Diagnostics' average media sentiment score of 1.51 beat Henry Schein's score of 0.93 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 9 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 22 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better valuation and earnings, HSIC or DGX? Quest Diagnostics has lower revenue, but higher earnings than Henry Schein. Quest Diagnostics is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHenry Schein$12.77B0.65$390M$3.1022.20Quest Diagnostics$9.87B2.05$871M$8.3521.64 Do analysts rate HSIC or DGX? Henry Schein currently has a consensus price target of $76.67, suggesting a potential upside of 11.42%. Quest Diagnostics has a consensus price target of $186.00, suggesting a potential upside of 2.93%. Given Henry Schein's higher probable upside, analysts plainly believe Henry Schein is more favorable than Quest Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42Quest Diagnostics 0 Sell rating(s) 10 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.50 Do insiders and institutionals hold more shares of HSIC or DGX? 96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by company insiders. Comparatively, 8.2% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is HSIC or DGX more profitable? Quest Diagnostics has a net margin of 9.01% compared to Henry Schein's net margin of 3.05%. Quest Diagnostics' return on equity of 15.24% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Henry Schein3.05% 14.36% 5.52% Quest Diagnostics 9.01%15.24%6.64% Which has more volatility and risk, HSIC or DGX? Henry Schein has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500. SummaryQuest Diagnostics beats Henry Schein on 12 of the 17 factors compared between the two stocks. Get Quest Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DGX vs. The Competition Export to ExcelMetricQuest DiagnosticsMED IndustryMedical SectorNYSE ExchangeMarket Cap$20.21B$4.10B$5.75B$21.50BDividend Yield1.75%1.28%5.72%3.49%P/E Ratio21.6428.7574.9929.84Price / Sales2.0525.46456.1051.75Price / Cash13.5426.8725.8118.13Price / Book2.944.4813.254.65Net Income$871M$189.47M$3.29B$999.94M7 Day Performance-1.00%-1.68%0.46%0.79%1 Month Performance0.58%2.15%4.59%4.54%1 Year Performance17.05%13.96%73.41%16.76% Quest Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DGXQuest Diagnostics4.7308 of 5 stars$180.71-1.2%$186.00+2.9%+18.4%$20.21B$9.87B21.6456,000Positive NewsHSICHenry Schein3.8366 of 5 stars$67.74-2.4%$76.67+13.2%-1.9%$8.21B$12.67B21.8525,000Positive NewsMEDPMedpace4.3185 of 5 stars$492.09+1.0%$412.73-16.1%+39.5%$13.82B$2.11B36.595,900Positive NewsAMNAMN Healthcare Services4.6382 of 5 stars$20.97+0.6%$28.25+34.7%-61.3%$803.61M$2.98B-2.702,968Positive NewsShort Interest ↓LHLabcorp4.655 of 5 stars$276.99-0.6%$290.33+4.8%+25.7%$23.02B$13.01B30.5770,000Positive NewsDVADaVita4.6473 of 5 stars$134.44-2.5%$164.00+22.0%-18.6%$9.61B$12.82B13.2276,000Analyst UpgradeCHEChemed4.9986 of 5 stars$464.58-0.2%$592.25+27.5%-22.4%$6.77B$2.43B23.8915,695Positive NewsShort Interest ↓CRVLCorVel2.0987 of 5 stars$90.34+5.7%N/A-19.0%$4.64B$895.59M46.575,075High Trading VolumeAMEDAmedisys2.0545 of 5 stars$101.01+0.0%$100.50-0.5%+4.2%$3.32B$2.40B39.3020,000MDPediatrix Medical Group2.1409 of 5 stars$16.95-0.7%$16.79-1.0%+52.5%$1.48B$2.01B13.144,305Positive NewsAnalyst DowngradeCCRNCross Country Healthcare3.7015 of 5 stars$14.05-0.4%$17.93+27.6%-11.4%$460.28M$1.34B-54.048,205Positive News Related Companies and Tools Related Companies Henry Schein Alternatives Medpace Alternatives AMN Healthcare Services Alternatives Labcorp Alternatives DaVita Alternatives Chemed Alternatives CorVel Alternatives Amedisys Alternatives Pediatrix Medical Group Alternatives Cross Country Healthcare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DGX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DGX Stock Alerts